The Ministry of Health and Family Welfare (MoHFW) on June 02, 2023, issued a notification regarding the prohibition of the manufacture, sale, or distribution of drugs for human use the fixed-dose combination of Salbutamol + Hydroxyethyltheophylline (Etofylline) + Bromhexine.
This shall come into force on June 02, 2023.
The following has been stated namely: -
•This is in supersession of the notification of the Government of India, Ministry of Health and Family Welfare Notification number S.O. 467(E) dated September 07, 2018.
•It has been decided to prohibit the manufacture for sale, sale, or distribution for human use of drug fixed dose combination Salbutamol + Hydroxyethyltheophylline (Etofylline) + Bromhexine with immediate effect.
[Notification No. S.O. 2407(E)]
